ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,849Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 244

$2.01M Total Retail Price of All Prescriptions

Rank: 1 out of 244

579 Patients Receiving at Least One Drug in Part D
16%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 579 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 1,513 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$135 was the average price of a prescription from this provider, compared to $141 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
CLOZAPINE 710 17 1 4
RISPERIDONE 662 82 2 2
TRAZODONE HCL 660 128 3 1
OLANZAPINE 624 49 4 8
ZOLPIDEM TARTRATE 621 62 5 15
BUPROPION XL 620 85 6 11
SERTRALINE HCL 585 65 7 7
QUETIAPINE FUMARATE 472 34 8 3
VENLAFAXINE HCL ER 458 50 9 9
CITALOPRAM HBR 456 60 10 6
ABILIFY 422 74 11 5
DIVALPROEX SODIUM ER 408 0 12 16
BUSPIRONE HCL 390 42 13 18
FLUOXETINE HCL 388 40 14 13
MIRTAZAPINE 373 72 15 14
BENZTROPINE MESYLATE 357 0 R 16 17
LAMOTRIGINE 349 0 17 12
CYMBALTA 328 51 18 10
PAROXETINE HCL 303 51 19 23
DIVALPROEX SODIUM 262 12 20 25
ESCITALOPRAM OXALATE 260 32 21 20
LITHIUM CARBONATE 241 16 22 22
GABAPENTIN 224 15 23 21
SEROQUEL 181 0 24 19
AMPHETAMINE SALT COMBO 174 49 S2 25 30
TOPIRAMATE 143 0 26 27
PROPRANOLOL HCL 128 0 27 36
ZIPRASIDONE HCL 124 0 28 26
PRISTIQ ER 122 12 29 41
LATUDA 120 0 30 44
LUNESTA 119 31 31 37
ZOLPIDEM TARTRATE ER 117 11 10 32 62
METHYLPHENIDATE HCL 111 0 33 38
FAZACLO 110 0 34 48
FLUVOXAMINE MALEATE 108 16 35 42
DEXTROAMPHETAMINE-AMPHETAMINE 96 11 S2 36 40
DOXEPIN HCL 96 0 36 49
HALOPERIDOL 95 0 38 29
HYDROXYZINE PAMOATE 93 0 R 39 32
VIIBRYD 91 0 40 56
INVEGA 90 0 41 54
BUPROPION HCL SR 78 45 42 24
STRATTERA 76 0 43 82
OXCARBAZEPINE 70 0 44 33
METFORMIN HCL 67 0 45 97
VENLAFAXINE HCL 66 13 46 47
LEXAPRO 65 0 47 39
GEODON 63 0 48 55
FANAPT 63 0 48 60
RISPERDAL CONSTA 62 0 50 28
AMITRIPTYLINE HCL 56 0 R 51 50
NALTREXONE HCL 51 0 52 111
PRAZOSIN HCL 50 0 53 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.